cholestyramine powder for suspension

Generic: cholestyramine powder for suspension

Labeler: ascend laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cholestyramine powder for suspension
Generic Name cholestyramine powder for suspension
Labeler ascend laboratories, llc
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

cholestyramine 4 g/8.78g

Manufacturer
Ascend Laboratories, LLC

Identifiers & Regulatory

Product NDC 67877-298
Product ID 67877-298_2871b3b9-3aa9-44b6-99ce-eab69a607bcb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211856
Listing Expiration 2026-12-31
Marketing Start 2021-10-20

Pharmacologic Class

Established (EPC)
bile acid sequestrant [epc]
Mechanism of Action
bile-acid binding activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67877298
Hyphenated Format 67877-298

Supplemental Identifiers

RxCUI
848943
UNII
4B33BGI082
NUI
N0000180292 N0000175365

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cholestyramine powder for suspension (source: ndc)
Generic Name cholestyramine powder for suspension (source: ndc)
Application Number ANDA211856 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 g/8.78g
source: ndc
Packaging
  • 368.76 g in 1 JAR (67877-298-37)
  • 60 POUCH in 1 CARTON (67877-298-60) / 8.78 g in 1 POUCH (67877-298-09)
source: ndc

Packages (2)

Ingredients (1)

cholestyramine (4 g/8.78g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2871b3b9-3aa9-44b6-99ce-eab69a607bcb", "openfda": {"nui": ["N0000180292", "N0000175365"], "unii": ["4B33BGI082"], "rxcui": ["848943"], "spl_set_id": ["430ac07e-8524-4dec-a599-b7ebc56d9563"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "368.76 g in 1 JAR (67877-298-37)", "package_ndc": "67877-298-37", "marketing_start_date": "20211020"}, {"sample": false, "description": "60 POUCH in 1 CARTON (67877-298-60)  / 8.78 g in 1 POUCH (67877-298-09)", "package_ndc": "67877-298-60", "marketing_start_date": "20211020"}], "brand_name": "cholestyramine powder for suspension", "product_id": "67877-298_2871b3b9-3aa9-44b6-99ce-eab69a607bcb", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "67877-298", "generic_name": "cholestyramine powder for suspension", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cholestyramine powder for suspension", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/8.78g"}], "application_number": "ANDA211856", "marketing_category": "ANDA", "marketing_start_date": "20211020", "listing_expiration_date": "20261231"}